A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the Gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy
Through this triple-receptor agonism, retatrutide not only lowers blood glucose levels and enhances insulin sensitivity but also suppresses appetite, increases energy expenditure, and reduces body weight
The pre-filled injector pen is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week
The primary difference is the approved indication,, Ozempic for diabetes, Wegovy for weight management, and the dosing
Consistency matters far more than dose
Ameliorating immune-dependent inflammation and apoptosis by targeting TLR4/MYD88/NF-B pathway by celastrol mitigates the diabetic reproductive dysfunction